This issue of Emergency Medicine Clinics focuses on Clinical Toxicology and is edited by Drs. Daniel Lugassy and Silas Smith and includes such topics as Emerging Drugs of Abuse, Pediatric Toxicology; Dosing and Medical Errors and Child Abuse, The Approach to Toxin-Induced Coagulopathy, The Approach to Toxin-Induced Cardiovascular Failure, The Approach to Toxin-Induced Metabolic Acidosis, The Approach to Withdrawal Syndromes, The Approach to Radiation Exposure, and more.FFPshould not be used foran elevated INR absent signsofhemorrhage. 47, 127, 132 IntheUnited States, FFPisalso recommended ... the amount of FFP commonly needed to reverse bleeding complications mayinduce heart failure and pulmonary edema. ... Threefactor PCCdoescontain smallamountsoffactor VII: ac0.35 IU factor VII per IU factor IX (Profilnine) and ac0.20 IU factor VII per ... from anticoagulants.138 PCCs are abletoreduce theINR much more rapidlywhen comparedwithFFP.
|Title||:||Clinical Toxicology, An Issue of Emergency Medicine Clinics of North America,|
|Author||:||Daniel M Lugassy|
|Publisher||:||Elsevier Health Sciences - 2014-02-09|